Kearns Evan

Insider profile

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Kearns Evan's trades of Cogent Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-30 2025-12-26 S Sale
78,264 -36.7%
450.45
US$3,224,472
78,264 -36.7% 450.45 US$3,224,472
2025-12-29 2025-12-26 PrS Proposed sale
72,237
364.86
US$2,677,952
72,237 364.86 US$2,677,952